These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11097340)

  • 41. Heterogeneity of toxicant response: sources of human variability.
    Aldridge JE; Gibbons JA; Flaherty MM; Kreider ML; Romano JA; Levin ED
    Toxicol Sci; 2003 Nov; 76(1):3-20. PubMed ID: 12883075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
    Serpe L; Canaparo R; Scordo MG; Spina E
    Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug metabolism polymorphisms as modulators of cancer susceptibility.
    Taningher M; Malacarne D; Izzotti A; Ugolini D; Parodi S
    Mutat Res; 1999 May; 436(3):227-61. PubMed ID: 10354524
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene-environment interactions in esophageal cancer.
    Matejcic M; Iqbal Parker M
    Crit Rev Clin Lab Sci; 2015; 52(5):211-31. PubMed ID: 26220475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis.
    Hernando-Rodriguez M; Rey-Barja N; Marichalar-Mendia X; Rodriguez-Tojo MJ; Acha-Sagredo A; Aguirre-Urizar JM
    J Oral Pathol Med; 2012 Jan; 41(1):1-8. PubMed ID: 21793938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD.
    Hukkanen J; Pelkonen O; Raunio H
    Eur Respir J Suppl; 2001 Sep; 32():122s-126s. PubMed ID: 11816819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
    Cerda A; Hirata MH; Hirata RD
    Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.
    Umamaheswaran G; Kumar DK; Adithan C
    Indian J Med Res; 2014 Jan; 139(1):27-65. PubMed ID: 24604039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical role of genetic polymorphisms in drug-metabolizing enzymes.
    Tomalik-Scharte D; Lazar A; Fuhr U; Kirchheiner J
    Pharmacogenomics J; 2008 Feb; 8(1):4-15. PubMed ID: 17549068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some aspects of interindividual variations in the metabolism of xenobiotics.
    Tamási V; Vereczkey L; Falus A; Monostory K
    Inflamm Res; 2003 Aug; 52(8):322-33. PubMed ID: 14504670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
    Zhu R; Xia Z
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hereditary polymorphisms of human drug metabolizing enzymes and cancer susceptibility.
    Gonzalez FJ
    Birth Defects Orig Artic Ser; 1990; 26(1):17-42. PubMed ID: 2224077
    [No Abstract]   [Full Text] [Related]  

  • 53. [Genetic polymorphism of enzymes metabolizing xenobiotics as a factor in susceptibility to tumor development].
    Salagovic J; Kalina I; Dudas M
    Bratisl Lek Listy; 2000; 101(9):512-21. PubMed ID: 11187056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure of epidemiological studies on genetic susceptibility to environmental toxicants.
    Taioli E
    Toxicol Lett; 2002 Feb; 127(1-3):315-9. PubMed ID: 12052672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility.
    Gonzalez FJ
    Reprod Toxicol; 1997; 11(2-3):397-412. PubMed ID: 9100315
    [No Abstract]   [Full Text] [Related]  

  • 56. Individual expression of carcinogen-metabolizing enzymes: cytochrome P4502A.
    Pelkonen O; Raunio H
    J Occup Environ Med; 1995 Jan; 37(1):19-24. PubMed ID: 7620939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combinations of susceptible genotypes and individual responses to toxicants.
    Hirvonen A
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):755-8. PubMed ID: 9255557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes.
    Ingelman-Sundberg M
    Mutat Res; 2001 Oct; 482(1-2):11-9. PubMed ID: 11535244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of DNA methylation landscape reveals the roles of DNA methylation in the regulation of drug metabolizing enzymes.
    Habano W; Kawamura K; Iizuka N; Terashima J; Sugai T; Ozawa S
    Clin Epigenetics; 2015; 7():105. PubMed ID: 26421064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-metabolizing enzymes in ligand-modulated transcription.
    Nebert DW
    Biochem Pharmacol; 1994 Jan; 47(1):25-37. PubMed ID: 8311842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.